(lp0
S"Threshold Pharmaceuticals' stock plunges after drug trial disappoints MarketWatch - Dec 7, 2015 Threshold Pharmaceuticals Inc.'s stock plunged in very active trade to a seven-year low Monday, after two late-stage trials of its investigational cancer treatment failed to meet their primary endpoints.Why Threshold Pharma Is Imploding - 24/7 Wall St.Merck KGaA Drops Cancer Drug Development After Studies Fail - Bloomberg"
p1
aS"Threshold Pharma  Says Two Studies Didn't Meet Activity Thresholds ... StreetInsider.com - Sep 29, 2016 On September 29, 2016, the Compensation Committee of the Board of Directors  of Threshold Pharmaceuticals, Inc.  committed to implementing a workforce reduction constituting approximately&nbsp;...Is There Value In The Threshold Pharmaceuticals, Inc.  Sell Off? - Market Exclusive"
p2
aS'Analysts Weigh in on Two Collapsing Biotech Stocks: Threshold Pharmaceuticals ... Smarter Analyst - Sep 30, 2016 The biotech world is experiencing volatility in the midst of a drug development discontinuation for Threshold Pharmaceuticals, Inc.  and word from the FDA to place a drug program on full clinical hold for Alcobra Ltd (NASDAQ:ADHD ...'
p3
aS'Threshold Pharmaceuticals, Inc.  Might Just Have Become A Buyout ... Insider Financial - Oct 5, 2016 Threshold Pharmaceuticals, Inc.  collapsed last week on the announcement that its lead trial had missed its primary endpoint.'
p4
aS'Lookout for Price Target? Dynegy Inc. , Threshold Pharmaceuticals, Inc ... StockNewsJournal - Mar 14, 2017 Threshold Pharmaceuticals, Inc. , at its latest closing price of $0.66, it has a price-to-book ratio of 1.86, compared to an industry average at 9.98.Threshold Pharmaceuticals, Inc.  added to 5 new portfolios - Post AnalystHot Stock to Watch: Threshold Pharmaceuticals Inc.  - FactsReporter'
p5
aS'Threshold Pharmaceuticals: Twice Bitten, Thrice Shy? Seeking Alpha - Nov 28, 2016 Threshold Pharmaceuticals Inc  is a biopharmaceutical company in operation since the mid 2000s, with projects in the tumor/cancer treatment environment.'
p6
aS'Caris Life Sciences and Threshold Pharmaceuticals Collaborate to Utilize Caris ... PR Newswire  - Oct 25, 2016 IRVING, Texas and SOUTH SAN FRANCISCO, Calif., Oct. 25, 2016 /PRNewswire/ -- Caris Life Sciences, a leading biotechnology company focused on fulfilling the promise of precision medicine, and Threshold Pharmaceuticals, Inc. ,&nbsp;...'
p7
aS"BRIEF-Threshold Pharmaceuticals, National Cancer Institute to collaborate on ... Reuters - Dec 19, 2016 Feb 17 Citigroup Inc's board of directors cut Chief Executive Officer Michael Corbat's compensation by 6 percent last year after the bank missed financial targets and one-third of its voting shareholders disapproved of his prior pay package."
p8
aS"Analysts Take Aim At This Stock's Earnings Estimates: Threshold ... Aiken Advocate - 14 hours ago Threshold Pharmaceuticals, Inc.  has a current consensus EPS estimate for the quarter of $N/A based on Street analyst predictions."
p9
aS'Threshold Pharmaceuticals Reports Third Quarter Financial Results GlobeNewswire  - Nov 7, 2016 SOUTH SAN FRANCISCO, Calif., Nov. 07, 2016  -- Threshold Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company developing novel therapies for cancer, today reported financial results for the third quarter&nbsp;...'
p10
a.